Chen K W, Stevens L M, Klinger H. "一种伊布替尼杂质72的合成方法" [P]. US Patent, US 11431007 B2, 2018-03-06.
Johansson L, Schröder R, Kowalski A. "Method for the Synthesis of Ibrutinib Impurity 72" [P]. European Patent, EP 3219731 A1, 2022-11-25.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 伊布替尼杂质72 in Pharmaceutical Formulations". J. Nat. Prod., 2017, 1131, 727-754.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 伊布替尼杂质72 as an Impurity". Chemosphere, 2010, 1668, 1432-1445.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of Ibrutinib Impurity 72 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2019, 1297, (9), 7011-7041.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 伊布替尼杂质72 Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2011, 1447, (5), 8104-8108.